why did the fda ban tirzepatide π¨ Moves to Shut Down Mass-Market Compounded GLP-1s FDA is taking action to restrict widely marketed, nonβFDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand FDA Drug Recalls and Warnings:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 8 - Aug 13
















:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)







